Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

18 May 2017

Speaking at the B20 Health Conference in Berlin, IFPMA Director-General […]

Read more

Biosimilar Medicines Opportunity: Dramatic Increase in Patient Access across Europe

9 May 2017

The new report on The Impact of Biosimilar Competition in […]

Read more

Industry Welcomes the 3rd European Commission Workshop on Biosimilar Medicines

5 May 2017

The European pharmaceutical industry welcomes the 3rd workshop on access […]

Read more

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

Over 100 participants explored different ways and opportunities to ensure […]

Read more

Biosimilars at work: Access. Experience. Science.

1 April 2017

Biosimilar medicines are a part of today’s therapeutic armamentarium – […]

Read more

22nd EAHP Conference in Cannes

25 March 2017

A special satellite  symposium was organized on “Value added medicines […]

Read more

Biosimilar Medicines: a Game Changer for Oncology Care

23 March 2017

With 10 years of positive experience with biosimilar medicines, medical […]

Read more

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

READ MORE

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

Key authorities, eminent lawyers and industry leaders discussed today in […]

Read more

Biosimilar interchangeability: Do you know your switching from your substitution?

21 March 2017

US FDA interchangeability guidance adds another level of confusion over […]

Read more

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]